HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
about
Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis.Digging deep into "dirty" drugs - modulation of the methylation machinery.A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cellsFOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition.Relapse assessment following allogeneic SCT in patients with MDS and AML.Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.Epigenetics in T-cell acute lymphoblastic leukemia.Cancer stem cells in haematological malignancies.Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity.Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromes.Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells.CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemiaDNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemiaRNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AMLEpigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia.Cancer Stem Cells.HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties
P2860
Q35726371-FDA35D7E-63B2-41C7-AE6B-13671E7541C4Q36250104-969C10F4-FFEF-483A-B404-AD550BDA5701Q36523796-A212B90A-EA96-47C4-8BD2-5C29C48CB15BQ36772066-A73D54EB-CE38-4C69-B41A-53ACF3280BEDQ36786443-C0392286-0042-4E2D-846C-716D6D24229EQ38199623-89AD1A9C-440F-433C-88F5-AC89F8F2A995Q38253011-4A8FC035-76FC-40C0-B5F3-76375692327EQ38289023-40DBADE7-D18B-45E4-8CF4-9E6A9A2C09DBQ38359714-6BFA824A-2D32-4015-AAE3-E59F2BE589A7Q38910479-7A876D1F-5DEE-40F0-B668-17451172BF5EQ41039704-9AEF1AD3-5F27-4E4D-82C1-595556DB8962Q41909687-D907C182-6C00-40D4-8FB7-0C10E7AC0D94Q42323497-54E0AFE9-ACCC-4742-B28C-3DEFBD1546C2Q42610015-2892DA97-3F87-45DA-9C1A-099EC89942E3Q42734570-BD2D7C82-13C0-4D19-AEE3-A33870EAE5ACQ51000809-66DCF856-9C4D-40CF-84E6-DAD644F68234Q53040917-D276E6CB-EAF9-4884-A259-DD41E0DB37ECQ56530315-B3DA0C94-527C-4318-94C5-0C7A0AFECABF
P2860
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
@en
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
@nl
type
label
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
@en
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
@nl
prefLabel
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
@en
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
@nl
P2093
P2860
P50
P356
P1476
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
@en
P2093
Amit Verma
Ari Melnick
Boris Bartholdy
John M Greally
Ross L Levine
Tihomira I Todorova
Tushar D Bhagat
Ulrich Steidl
Yongkai Mo
P2860
P304
P356
10.1172/JCI71264
P407
P577
2014-03-01T00:00:00Z